David Baer, DPM
Primary Podiatric Medicine · Columbiana, OHNPI 1093710808
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,400 of the $3,043 with a category attached, or 78.9%. 6 manufacturers reported payments, led by Mid-atlantic Surgical Systems, LLC at 48.5% of the total. Reporting peaked in 2022 at $2,739 and has fallen 97.0% since, to $83 in 2025.
Across 11 payments — averaging $276.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mid-atlantic Surgical Systems, LLC$1K
- Arthrex$1K
- Integra Lifesciences Corporation$121
- Treace Medical Concepts, Inc.$120
- AbbVie$83
- Averitas Pharma Inc.$18
What the payments were for
- Travel & lodging$1585%
- Food & beverage$48516%
- Education$2,40079%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mid-atlantic Surgical Systems, LLC | 5 | $1,476 |
| Arthrex | 2 | $1,224 |
| Integra Lifesciences Corporation | 1 | $121 |
| Treace Medical Concepts, Inc. | 1 | $120 |
| AbbVie | 1 | $83 |
| Averitas Pharma Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few primary podiatric medicine providers in Ohioto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 157 | $7,545 |
| Ciclopirox | 111 | $6,129 |
| Gabapentin | 283 | $4,071 |
| Celecoxib | 40 | $1,710 |
| Diclofenac Sodium | 35 | $1,255 |
| Duloxetine Hcl | 55 | $1,206 |
| Ammonium Lactate | 71 | $1,116 |
| Ketoconazole | 72 | $979 |
| Diclofenac Potassium | 19 | $902 |
| Clobetasol Propionate | 14 | $820 |
| Nabumetone | 26 | $734 |
| Doxycycline Hyclate | 61 | $629 |
| Ropinirole Hcl | 45 | $418 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 17 | $416 |
| Colchicine | 24 | $384 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Columbiana
- Matthew NarducciColumbiana$2K
- Brock LidenCircleville$453K
- Shital PemaKettering$299K
- Megan OltmannSolon$177K
- Gary MostChesterland$4K
- Thomas CiresiRichmond Heights$4K
- Tiffany LiuDublin$3K
- Abena AgyepongCincinnati$3K
- Samuel MakanjuolaColumbus$2K
- Joseph ArtersYoungstown$937
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.